GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
companies in this sector in the United States:
sales of $46.64 billion
of which 42%
was Pharmaceuticals & Biological Products),
of which 100%
was Pharmaceutical Products), and
Merck & Co. , Inc.
of which 89%
was Merck Pharmaceutical).
During the year ended December of 2018, sales at
GlaxoSmithKline plc were $41.01 billion.
increase of 4.3%
versus 2017, when the company's sales were $39.30 billion.
This was the third consecutive year of growth at GlaxoSmithKline plc.
The sales level in 2018 was fairly close to the level five years ago: in 2013, GlaxoSmithKline plc had sales
of $41.52 billion.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
16.7% in 2018, from
$6.72 billion to $7.84 billion.